Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P4HB | P07237 | 3/20 | 1.00 |
| ▸ | SYNJ2 | O15056 | 1/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.85 |
| ▸ | MAPT | P10636 | 3/20 | 0.85 |
| ▸ | HES1 | Q14469 | 2/20 | 0.85 |
| ▸ | FANCF | Q9NPI8 | 2/20 | 0.85 |
| ▸ | POLB | P06746 | 2/20 | 0.85 |
| ▸ | GAA | P10253 | 2/20 | 0.85 |
| ▸ | XDH | P47989 | 2/20 | 0.85 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.85 |
| ▸ | KDM1A | O60341 | 1/20 | 0.85 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.85 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.85 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.85 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.85 |
| ▸ | CFTR | P13569 | 1/20 | 0.85 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.85 |
| ▸ | MAOA | P21397 | 1/20 | 0.85 |
| ▸ | ACHE | P22303 | 1/20 | 0.85 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Narcissin SCHEMBL31236364 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL1305421 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL30389758 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL7167500 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL15773535 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL29516911 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Narcissin SCHEMBL31236367 | 1.00 | P4HB (1.00) | P4HBSYNJ2KDM4EMAPTHES1 | |
| Rutin SCHEMBL6427268 | 0.95 | P4HB (0.90) | P4HBSYNJ2KDM4EMAPTHES1 | |
| SCHEMBL30305712 | 0.95 | P4HB (0.90) | P4HBSYNJ2KDM4EMAPTHES1 | |
| SCHEMBL25292788 | 0.94 | P4HB (0.89) | P4HBSYNJ2KDM4EMAPTHES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 446 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4655410-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | Symrise AG (DE) | 2025-12-03 | — | — | EP | claimed |
| EP-4650770-A1 | METHOD FOR CONSTRUCTING CHICORY-PORIA COMPOUND FINGERPRINT, AND FINGERPRINT AND USE THEREOF | Beijing University of Chinese Medicine (CN) | 2025-11-19 | — | — | EP | claimed |
| EP-4558157-A1 | ANHYDROUS EXTRACT OF STEMLESS LEAVES OF HIPPOPHAE RHAMNOIDES OR COMPOSITION COMPRISING SAID EXTRACT FOR USE IN MAINTAINING AND/OR IMPROVING SKIN MICROCIRCULATION | GATTEFOSSE SAS (FR) | 2025-05-28 | — | — | EP | claimed |
| WO-2025035717-A1 | METHOD FOR CONSTRUCTING CHICORY-PORIA COMPOUND FINGERPRINT, AND FINGERPRINT AND USE THEREOF | 北京中医药大学 | 2025-02-20 | — | — | WO | claimed |
| WO-2024156879-A2 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| WO-2024156359-A1 | O-METHYLATION OF PHENOLIC SUBSTANCES VIA FUNGAL O-METHYLTRANSFERASE | SYMRISE AG (DE) | 2024-08-02 | — | — | WO | claimed |
| WO-2024018160-A1 | ANHYDROUS EXTRACT OF STEMLESS LEAVES OF HIPPOPHAE RHAMNOIDES OR COMPOSITION COMPRISING SAID EXTRACT FOR USE IN MAINTAINING AND/OR IMPROVING SKIN MICROCIRCULATION | GATTEFOSSE SAS (FR) | 2024-01-25 | — | — | WO | claimed |
| WO-2023219526-A1 | MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT | PROKIN MILAN (RS) | 2023-11-16 | — | — | WO | claimed |
| WO-2023284777-A1 | COPOLYMER FILM, ENZYME CATALYSIS SELF-ASSEMBLY SYNTHESIS METHOD THEREFOR, AND APPLICATION THEREOF | 中国科学院天津工业生物技术研究所 | 2023-01-19 | — | — | WO | claimed |
| CN-115612699-A | Copolymer membrane and enzymatic self-assembly synthesis method and application thereof at gas-liquid interface | 中国科学院天津工业生物技术研究所 | 2023-01-17 | — | — | CN | claimed |
| US-20030104082-A1 | Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases | MCGINLEY PARTNERS, LLC (US) | 2003-06-05 | — | — | US | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| CN-1258191-A | Antimicrobial prevention and treatment of human immunodeficiency virus and other infectious diseases | MERYL SQUIRES (US) | 2000-06-28 | — | — | CN | claimed |
| US-6063383-A | Pharmaceutical suppository composites for fever and influenza and method of producing the composites | HSU WU-CHING (TW) | 2000-05-16 | — | — | US | claimed |
| EP-0980203-A1 | ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES | Squires, Meryl (US) | 2000-02-23 | — | — | EP | claimed |
| US-6004560-A | OBTAINING A LIQUID BY BOILING BUPLEURUM SCORZONERIFOLIUM WILLD, RADIX LASTIDIS INDIGOTICA AND FOLIUM LASTIDIS FOR A LONG TIME IN WATER, AND THEN MIXING THE LIQUID THUS OBTAINED WITH VITAMIN C | HSU WU-CHING (TW) | 1999-12-21 | — | — | US | claimed |
| WO-1998042188-A1 | ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 1998-10-01 | — | — | WO | claimed |
| US-4617293-A | Flavonoid phosphate salts of aminoglycoside antibiotics | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1986-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030104082-A1 | Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases | CD14, CD59, SLC19A1 | P4HB 3521/4885SYNJ2 4493/4885KDM4E 3962/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.